KR20120081585A - 안질환을 치료하기 위한 이소티오졸 - Google Patents

안질환을 치료하기 위한 이소티오졸 Download PDF

Info

Publication number
KR20120081585A
KR20120081585A KR1020127006129A KR20127006129A KR20120081585A KR 20120081585 A KR20120081585 A KR 20120081585A KR 1020127006129 A KR1020127006129 A KR 1020127006129A KR 20127006129 A KR20127006129 A KR 20127006129A KR 20120081585 A KR20120081585 A KR 20120081585A
Authority
KR
South Korea
Prior art keywords
retinal
eye
disease
diseases
isothiozoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020127006129A
Other languages
English (en)
Korean (ko)
Inventor
비나 비스워나스
존 이. 도넬로
Original Assignee
알러간, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알러간, 인코포레이티드 filed Critical 알러간, 인코포레이티드
Publication of KR20120081585A publication Critical patent/KR20120081585A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020127006129A 2009-08-11 2010-08-10 안질환을 치료하기 위한 이소티오졸 Withdrawn KR20120081585A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23304709P 2009-08-11 2009-08-11
US61/233,047 2009-08-11

Publications (1)

Publication Number Publication Date
KR20120081585A true KR20120081585A (ko) 2012-07-19

Family

ID=43007053

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127006129A Withdrawn KR20120081585A (ko) 2009-08-11 2010-08-10 안질환을 치료하기 위한 이소티오졸

Country Status (11)

Country Link
US (1) US20110039900A1 (enExample)
EP (1) EP2464351A1 (enExample)
JP (1) JP2013501794A (enExample)
KR (1) KR20120081585A (enExample)
CN (1) CN102695505A (enExample)
AU (1) AU2010282698A1 (enExample)
BR (1) BR112012003284A8 (enExample)
CA (1) CA2770894A1 (enExample)
IN (1) IN2012DN01846A (enExample)
RU (1) RU2012105453A (enExample)
WO (1) WO2011019678A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3193867T (pt) 2014-09-17 2021-03-09 Panoptica Inc Formulações oculares para administração de fármaco e proteção do segmento anterior do olho
IL251949A0 (en) 2017-04-26 2017-07-31 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Small organic molecules for use in the treatment of neuro-inflammatory diseases
EP3897670A4 (en) 2018-12-19 2022-09-07 Disarm Therapeutics, Inc. MRSA1 INHIBITORS IN COMBINATION WITH NEUROPROTECTIVE AGENTS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6989451B2 (en) * 2002-06-04 2006-01-24 Valeant Research & Development Heterocyclic compounds and uses thereof
PT1802579E (pt) * 2004-10-20 2014-02-17 Merck Serono Sa Derivados da 3-arilaminopiridina
US20080025973A1 (en) * 2006-07-25 2008-01-31 Alcon Manufacturing, Ltd. Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders

Also Published As

Publication number Publication date
AU2010282698A1 (en) 2012-03-15
RU2012105453A (ru) 2013-09-20
JP2013501794A (ja) 2013-01-17
BR112012003284A8 (pt) 2016-05-17
IN2012DN01846A (enExample) 2015-08-21
WO2011019678A1 (en) 2011-02-17
BR112012003284A2 (pt) 2016-03-01
US20110039900A1 (en) 2011-02-17
CA2770894A1 (en) 2011-02-17
EP2464351A1 (en) 2012-06-20
CN102695505A (zh) 2012-09-26

Similar Documents

Publication Publication Date Title
JP6483148B2 (ja) ＨＰＴＰ−β阻害剤
JP6865254B2 (ja) 眼疾患を処置するための組成物、製剤、および方法
HRP20220138T1 (hr) Peptidni pripravci i postupci uporabe
JP2015520130A5 (enExample)
JP2018514590A5 (enExample)
KR20160126983A (ko) 안내 혈관신생 및/또는 누출 치료용 조성물 및 방법
JP5875585B2 (ja) 緑内障および高眼圧症の処置のためのアデノシンａ１アゴニスト
US20200108064A1 (en) Low-dose brimonidine combinations and uses thereof
JP2009500409A (ja) 痛みを処置するためのα２アドレナリン作動剤
KR20120081585A (ko) 안질환을 치료하기 위한 이소티오졸
US20170172959A1 (en) D-serine for the treatment of visual system disorders
AU2004296748B2 (en) Prevention and/or reduction of photoreceptor degeneration with retinoids
CN102762195A (zh) 前列腺素拮抗剂前药的稳定水性组合物及其使用方法
US7612082B2 (en) Prostaglandin EP4 antagonists
US20200197398A1 (en) Netarsudil and low-dose brimonidine combination and uses thereof
US20130046003A1 (en) Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases
US20110257186A1 (en) Compositions and methods for treating visual disorders

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20120308

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid